Shree Ganesh Remedies Limited (SGRL)

BSE: ₹642.15
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2020 Sep 2021 Dec 2021 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 31.65 16.97 21.13 37.33 24.78 32.33 27.05 24.43 24.67 30.32 21.11 33.20
YOY Revenue Growth % - - - - -21.7% 90.53% 28.04% -34.55% -0.45% -6.24% -21.98% 35.87%
Other Income 2.20 0.44 0.88 1.32 0.54 0.19 0.71 2.29 0.66 0.69 0.66 1.02
Total Income 33.85 17.41 22.01 38.66 25.32 32.52 27.76 26.72 25.33 31.00 21.76 34.22
Total Expenses + 27.10 13.51 16.37 22.41 18.99 23.88 20.24 17.94 20.73 24.29 17.78 25.50
Cost of Materials Consumed 18.47 8.92 9.06 12.16 8.84 8.80 10.23 9.51 8.74 12.20 8.95 11.03
Employee Benefit Expense 2.67 1.06 1.21 2.82 2.35 2.41 2.66 2.69 2.70 2.97 2.86 2.87
Other Expenses 5.72 2.54 3.32 4.52 5.91 5.37 6.09 6.02 5.95 5.14 5.18 4.72
Operating Profit 4.55 3.46 4.76 14.92 5.79 8.45 6.82 6.49 3.94 6.02 3.33 7.70
OPM % 14.4% 20.4% 22.5% 40% 23.4% 26.1% 25.2% 26.6% 16% 19.9% 15.8% 23.2%
Profit Before Tax + 6.75 3.90 5.64 16.24 6.33 8.64 7.53 8.77 4.60 6.71 3.98 8.72
Tax Expense 1.46 0.88 1.43 3.66 1.68 2.23 2.10 2.18 1.15 1.76 0.89 2.45
Tax % 21.7% 22.7% 25.4% 22.5% 26.6% 25.8% 27.9% 24.9% 25.1% 26.2% 22.4% 28.1%
Profit After Tax 5.29 3.02 4.20 12.58 4.65 6.41 5.42 6.59 3.45 4.96 3.09 6.27
EPS (Basic) 5.90 3.02 3.50 10.00 3.62 4.97 4.22 5.13 2.68 3.86 2.41 4.88

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2020
Revenue from Operations 109.29 108.60 125.90 64.02
YOY Revenue Growth % 0.63% -13.74% 96.65% -
Other Income 3.03 3.73 3.07 3.91
Total Income 112.32 112.33 128.96 67.93
Total Expenses + 88.30 81.06 90.80 54.34
Cost of Materials Consumed 40.92 37.38 61.05 38.31
Employee Benefit Expense 11.40 10.12 8.41 3.99
Other Expenses 20.99 23.39 18.23 9.59
Operating Profit 20.98 27.54 35.09 9.68
OPM % 19.2% 25.4% 27.9% 15.1%
Profit Before Exceptional 24.01 31.27 38.16 13.59
Exceptional Items 0.00 0.00 0.00 0.00
Profit Before Tax + 24.01 31.27 38.16 13.59
Tax Expense 6.26 8.20 10.05 3.12
Tax % 26% 26.2% 26.3% 23%
Profit After Tax 17.76 23.07 28.11 10.47
EPS (Basic) 13.83 17.96 22.34 11.67

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2020
ASSETS
Non-Current Assets + 121.82 114.37 100.73 21.46
Property, Plant & Equipment 68.08 57.91 80.48 18.67
Capital Work in Progress 12.38 8.34 16.63 0.00
Non-Current Investments 0.08 0.08 0.08 0.07
Goodwill 0.00 0.00 0.00 0.00
Other Intangible Assets 36.57 37.09 0.07 1.47
Current Assets + 85.86 77.58 70.20 33.82
Inventories 24.01 22.02 24.99 6.41
Trade Receivables 32.57 22.27 20.33 17.79
Cash and Cash Equivalents 13.40 9.95 15.85 2.33
Current Investments 12.45 18.26 4.66 3.00
LIABILITIES & EQUITY
Total Equity 162.97 145.16 122.10 42.25
Equity Share Capital 12.84 12.84 12.84 8.97
Other Equity 150.13 132.32 109.25 33.23
Non-Current Liabilities 23.03 30.60 30.16 2.65
Current Liabilities 21.69 16.18 18.68 10.38
Total Liabilities 44.72 46.79 48.84 13.03

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2020
Cash from Operating Activities 23.74 30.66 30.45 0.00
Cash from Investing Activities -9.89 -35.66 -33.01 0.00
Cash from Financing Activities -11.70 -1.09 9.84 0.00
Net Increase/Decrease in Cash 3.45 -5.91 7.20 0.00